Companies: NeuralStem

Pharmalicensing.com

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

UTEK Corporation

Companies

Companies
Company details

NeuralStem

NeuralSTEM's proprietary human CNS stem cell technology forms the foundation for an entire suite of proprietary drug discovery technologies

The company in detail

All
Summary
R&D
Deals
Management

Summary

Neuralstem was founded in 1996 by Richard Garr and Karl K. Johe. NeuralStems intends to develop a new generation of therapeutics to treat neurodegenerative and neurological disorders. The Company's other founders are current President & CEO Richard Garr, JD, and Merrill Solomon.

R&D

To view this information, you must subscribe to PL Intelligence.

Partnerships

To view this information, you must subscribe to PL Intelligence.

Deals

To view this information, you must subscribe to PL Intelligence.

Senior management

To view this information, you must subscribe to PL Intelligence.

Board of directors

To view this information, you must subscribe to PL Intelligence.

Contact details

To view this information, you must subscribe to PL Intelligence.

Head office

NeuralStem
9700 Great Sene
Rockville
Maryland
20850
Maryland

Related companies

Decision Resources Inc.

Rubicon Research Private Limited

Porsolt & Partners Pharmacology

Related categories

Industry sector: Biotechnology / Assay systems; Biotechnology / Gene therapy; Drug discovery; Drug discovery / Bioinformatics; Drug discovery / Genomics; Research tools / Cell lines
Therapeutic target: Central Nervous System; Central Nervous System / CNS (other); Central Nervous System / Neurological / Epilepsy; Central Nervous System / Neurodegenerative disorders / Parkinson's disease

Clients in focus...

Get the Flash Player to see this rotator.

PharmAsia Summit 2009

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd All rights reserved. Terms and Conditions | Contact us